Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06057987
Other study ID # 687/23
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 14, 2023
Est. completion date August 2024

Study information

Verified date September 2023
Source Poznan University of Medical Sciences
Contact Sylwia Iwanczyk, MD, PhD
Phone +48 61-854-91-46
Email siwanczyk@ump.edu.pl
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The goal of this observational study is to comprehensively investigate the current prevalence, morphological characteristics, risk factors for the development, complications as well as long-term prognosis of coronary artery aneurysm and ectasia (CAAE) in the Polish population. Data obtained from the CARED-POL Registry will enable the selection of morphological risk factors for the unfavorable course of CAAE, including the progression and development of giant aneurysms, aneurysm clotting with vessel occlusion, and thromboembolic complications. Comparing the safety and effectiveness of available CAAE treatment methods in individual patient subgroups will allow individualization of treatment, including anticoagulant therapy.


Description:

Coronary artery aneurysm or ectasia (CAAE) is a rare vascular pathology diagnosed in 0.15-5.3% of patients undergoing coronary angiography. CAAEs are often diagnosed incidentally, while symptomatic patients experience various complications, including unstable angina, acute myocardial infarction, arrhythmias, or sudden cardiac death. The most common etiology of CAAE is atherosclerosis, Kawasaki disease, or other vasculitis. Detailed pathomechanisms and risk factors of unfavorable courses of CAAE have not yet been known. In addition, the data on Polish patients are limited to case reports, case series, and small groups from major academic centers. CARED-POL is a multicenter, observational nationwide registry of CAAE. Patients will be included ambispectively based on the angiographic diagnosis of coronary artery aneurysm (CAA) or coronary artery ectasia (CAE). All participating centers will enroll patients retrospectively based on their internal databases after evaluation of coronary angiography by an experienced interventional cardiologist and prospectively for six months from the CARED-POL joining. Angiographic assessment will be based on quantitative coronary angiography (QCA). The patient data will be collected from standardized and anonymous forms via the Scientific Platform of the Polish Society of Cardiology. In accordance with initial assumptions, 2,000 patients in all participating centers will be included. Patients included in the registry will undergo a minimum of 6 months of follow-up with assessment of the following endpoints: all-cause death, re-hospitalization for unstable angina, myocardial infarction, heart failure, bleeding, stroke, embolic events, and any cause for repeat coronary angiography. Data will be obtained from outpatient visits, medical records, or telephone interviews. In patients who undergo repeated coronary angiography, the formation of a new aneurysm or progression of an existing one will be detected. Aneurysm progression is diagnosed as an increase in size demonstrated on at least two orthogonal angiographic views.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date August 2024
Est. primary completion date July 14, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - CAA or CAE defined as a focal dilatation with a diameter of more than or equal to 1.5 times the adjacent normal coronary segment Exclusion Criteria: - the lack of informed consent for prospectively enrolled patients

Study Design


Locations

Country Name City State
Poland Poznan University of Medical Sciences, Poland Poznan Wielkopolska

Sponsors (1)

Lead Sponsor Collaborator
Poznan University of Medical Sciences

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of CAAE Incidence of CAAE in the Polish population based on coronary angiography 12 months
Primary All-cause death 6 months
Primary Re-hospitalization Re-hospitalization for unstable angina, myocardial infarction, heart failure, bleeding, stroke, embolic events 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05233124 - Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia Phase 2
Recruiting NCT05713201 - Outcomes After PCI of the Aneurysmatic Right Coronary Artery
Recruiting NCT04265989 - A New Classification and Interventional Therapy for Coronary Artery Ectasia N/A
Recruiting NCT00548457 - Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries N/A
Completed NCT02024919 - Effect of Diltiazem on Coronary Artery Ectasia N/A
Not yet recruiting NCT05213429 - Jordanian Coronary Artery Ectasia Registry
Completed NCT05410678 - Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries Phase 4
Recruiting NCT02831153 - Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method N/A
Recruiting NCT02818127 - Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI) N/A
Not yet recruiting NCT05692115 - Ischemia and Inflammatory Markers Among Patients With Coronary Artery Ectasia
Recruiting NCT05106530 - Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients
Not yet recruiting NCT05718531 - Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens. Phase 3
Completed NCT06220682 - Endothelial NO Synthase Polymorphic Gene in Coronary Artery Dilation Disease